Search compounds, pages, and insights
Mitragyna speciosa
Family · Rubiaceae
Mitragyna speciosa (kratom) is a tropical evergreen tree native to Southeast Asian rainforests. Its leaves contain a complex alkaloid profile centred on mitragynine and 7-hydroxymitragynine, which interact with opioid and adrenergic receptor systems. The plant is the subject of significant pharmacological research for novel analgesic pathways.
Kratom (Mitragyna speciosa) is supplied by Phyto-Medichem as a standardised extract from our manufacturing facility. Marker compound: Mitragynine (C23H30N2O4). Available now for commercial supply. Sourced from Thailand, Malaysia, Indonesia. Per-batch Certificate of Analysis from our in-house HPLC analytical laboratory.
| Marker compound | Mitragynine |
|---|---|
| Molecular formula | C23H30N2O4 |
| PubChem CID | 3034396 |
| Botanical family | Rubiaceae |
| Source region | Thailand, Malaysia, Indonesia |
| Pipeline stage | Commercial Supply |
| Commercial status | Commercial |
| Catalogue SKU | COM-KRA-001 |
C23H30N2O4
The principal characterised compound for Kratom. Structure data and identifiers sourced from PubChem.
View on PubChem (CID 3034396)Used for centuries by agricultural workers and labourers in Thailand and Malaysia as a stimulant at low doses and for pain relief at higher doses. Leaves were traditionally chewed fresh or brewed into a tea to combat fatigue during long working hours.
Commercial supply via standardised mitragynine-characterised extract. Ongoing research into structure-activity relationships of key constituents.
Regulatory status varies significantly by jurisdiction. Subject to ongoing regulatory review in multiple markets. Our research programme operates in full compliance with applicable national and international regulations.
Sourced from licensed cultivators in Thailand operating under government-approved frameworks, with full chain-of-custody documentation and rigorous quality controls at origin.
Selected reviews and primary studies indexed on PubMed / PMC. The mechanism-of-action framings on this page are drawn from peer-reviewed pharmacology; consult these sources for the underlying evidence and methodology.
Comprehensive review of pharmacological action and toxicology profile.
Structure-activity insights into mitragynine and related alkaloids.
Narrative review situating kratom in current clinical research context.
For research and ingredient-supply context only
Mechanism, traditional-use, and application descriptions on this page are presented as pharmacological research context for B2B formulators, buyers, and licensing partners. They do not constitute medical advice, regulatory claims, or a guarantee of therapeutic effect, and downstream product claims remain the responsibility of the formulator under their jurisdiction's regulations. See the regulatory notes block above for compound-specific market context.
A profile of the multi-generational Thai farms that supply our kratom — the rhythm of harvest, the shade-drying tradition, and what 34 provinces across four administrative regions actually looks like on the ground.
Read articleBotanical supply chains are notoriously layered. Here is why we think direct grower partnerships matter, and what genuinely documented chain-of-custody looks like in practice.
Read articleContact us to discuss licensing opportunities, custom development, or research partnerships around this compound.
